Literature DB >> 15785857

Size frequency distribution of prion protein (PrP) aggregates in variant Creutzfeldt-Jakob disease (vCJD).

R A Armstrong1, N J Cairns, J W Ironside, P L Lantos.   

Abstract

The frequency distribution of aggregate size of the diffuse and florid-type prion protein (PrP) plaques was studied in various brain regions in cases of variant Creutzfeldt-Jakob disease (vCJD). The size distributions were unimodal and positively skewed and resembled those of beta-amyloid (A beta) deposits in Alzheimer's disease (AD) and Down's syndrome (DS). The frequency distributions of the PrP aggregates were log-normal in shape, but there were deviations from the expected number of plaques in specific size classes. More diffuse plaques were observed in the modal size class and fewer in the larger size classes than expected and more florid plaques were present in the larger size classes compared with the log-normal model. It was concluded that the growth of the PrP aggregates in vCJD does not strictly follow a log-normal model, diffuse plaques growing to within a more restricted size range and florid plaques to larger sizes than predicted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785857     DOI: 10.1007/s00702-005-0296-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  20 in total

1.  Do beta-amyloid (Abeta) deposits in patients with Alzheimer's disease and Down's syndrome grow according to the log-normal model?

Authors:  R A Armstrong
Journal:  Neurosci Lett       Date:  1999-02-12       Impact factor: 3.046

Review 2.  Laboratory diagnosis of variant Creutzfeldt-Jakob disease.

Authors:  J W Ironside; M W Head; J E Bell; L McCardle; R G Will
Journal:  Histopathology       Date:  2000-07       Impact factor: 5.087

3.  The natural silk spinning process. A nucleation-dependent aggregation mechanism?

Authors:  G Li; P Zhou; Z Shao; X Xie; X Chen; H Wang; L Chunyu; T Yu
Journal:  Eur J Biochem       Date:  2001-12

4.  Submicroscopic immunodetection of PrP in the brain of a patient with a new-variant of Creutzfeldt-Jakob disease.

Authors:  V Grigoriev; F Escaig-Haye; N Streichenberger; N Kopp; J Langeveld; P Brown; J G Fournier
Journal:  Neurosci Lett       Date:  1999-04-02       Impact factor: 3.046

5.  The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.

Authors:  R A Armstrong; P L Lantos; N J Cairns
Journal:  Neurosci Lett       Date:  2001-01-26       Impact factor: 3.046

6.  Evidence for a diffusional model of Alzheimer amyloid A4 (beta-amyloid) deposition during neuritic plaque formation.

Authors:  F M Benes; J L Reifel; R E Majocha; C A Marotta
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

7.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.

Authors:  J A Hainfellner; J Wanschitz; K Jellinger; P P Liberski; F Gullotta; H Budka
Journal:  Acta Neuropathol       Date:  1998-08       Impact factor: 17.088

8.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

9.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

Authors:  A F Hill; R J Butterworth; S Joiner; G Jackson; M N Rossor; D J Thomas; A Frosh; N Tolley; J E Bell; M Spencer; A King; S Al-Sarraj; J W Ironside; P L Lantos; J Collinge
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

10.  Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host.

Authors:  C A McLean; J W Ironside; M P Alpers; P W Brown; L Cervenakova; R M Anderson; C L Masters
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.